Sequence of CATD_HUMAN

cathepsin D

P07339

412

44552

354779

Faust P.L.,Kornfeld S.,Chirgwin J.M.

Cloning and sequence analysis of cDNA for human cathepsin D.

Proc. Natl. Acad. Sci. U.S.A.

82

4910-4914

1985

354780

Westley B.R.,May F.E.B.

Oestrogen regulates cathepsin D mRNA levels in oestrogen responsive human breast cancer cells.

Nucleic Acids Res.

15

3773-3786

1987

354781

Redecker B.,Heckendorf B.,Grosch H.W.,Mersmann G.,Hasilik A.

Molecular organization of the human cathepsin D gene.

DNA Cell Biol.

10

423-431

1991

354784

The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).

Genome Res.

14

2121-2127

2004

354785

May F.E.,Smith D.J.,Westley B.R.

The human cathepsin D-encoding gene is transcribed from an estrogen-regulated and a constitutive start point.

Gene

134

277-282

1993

354786

Augereau P.,Miralles F.,Cavailles V.,Gaudelet C.,Parker M.,Rochefort H.

Characterization of the proximal estrogen-responsive element of human cathepsin D gene.

Mol. Endocrinol.

8

693-703

1994

354788

Kobayashi T.,Honke K.,Gasa S.,Fujii T.,Maguchi S.,Miyazaki T.,Makita A.

Proteolytic processing sites producing the mature form of human cathepsin D.

Int. J. Biochem.

24

1487-1491

1992

354789

Basrur V.,Yang F.,Kushimoto T.,Higashimoto Y.,Yasumoto K.,Valencia J.,Muller J.,Vieira W.D.,Watabe H.,Shabanowitz J.,Hearing V.J.,Hunt D.F.,Appella E.

Proteomic analysis of early melanosomes: identification of novel melanosomal proteins.

J. Proteome Res.

2

69-79

2003

354790

Zhang H.,Li X.-J.,Martin D.B.,Aebersold R.

Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry.

Nat. Biotechnol.

21

660-666

2003

354791

Liu T.,Qian W.-J.,Gritsenko M.A.,Camp D.G. II,Monroe M.E.,Moore R.J.,Smith R.D.

Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.

J. Proteome Res.

4

2070-2080

2005

354792

Siintola E.,Partanen S.,Stromme P.,Haapanen A.,Haltia M.,Maehlen J.,Lehesjoki A.E.,Tyynela J.

Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis.

Brain

129

1438-1445

2006

354793

Chi A.,Valencia J.C.,Hu Z.-Z.,Watabe H.,Yamaguchi H.,Mangini N.J.,Huang H.,Canfield V.A.,Cheng K.C.,Yang F.,Abe R.,Yamagishi S.,Shabanowitz J.,Hearing V.J.,Wu C.,Appella E.,Hunt D.F.

Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes.

J. Proteome Res.

5

3135-3144

2006

354794

Lewandrowski U.,Moebius J.,Walter U.,Sickmann A.

Elucidation of N-glycosylation sites on human platelet proteins: a glycoproteomic approach.

Mol. Cell. Proteomics

5

226-233

2006

354795

Chen R.,Jiang X.,Sun D.,Han G.,Wang F.,Ye M.,Wang L.,Zou H.

Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry.

J. Proteome Res.

8

651-661

2009

354796

Didangelos A.,Yin X.,Mandal K.,Baumert M.,Jahangiri M.,Mayr M.

Proteomics characterization of extracellular space components in the human aorta.

Mol. Cell. Proteomics

9

2048-2062

2010

354797

Burkard T.R.,Planyavsky M.,Kaupe I.,Breitwieser F.P.,Buerckstuemmer T.,Bennett K.L.,Superti-Furga G.,Colinge J.

Initial characterization of the human central proteome.

BMC Syst. Biol.

5

17-17

2011

354798

Halim A.,Ruetschi U.,Larson G.,Nilsson J.

LC-MS/MS characterization of O-glycosylation sites and glycan structures of human cerebrospinal fluid glycoproteins.

J. Proteome Res.

12

573-584

2013

354799

Vaca Jacome A.S.,Rabilloud T.,Schaeffer-Reiss C.,Rompais M.,Ayoub D.,Lane L.,Bairoch A.,Van Dorsselaer A.,Carapito C.

N-terminome analysis of the human mitochondrial proteome.

Proteomics

15

2519-2524

2015

354800

Letronne F.,Laumet G.,Ayral A.M.,Chapuis J.,Demiautte F.,Laga M.,Vandenberghe M.E.,Malmanche N.,Leroux F.,Eysert F.,Sottejeau Y.,Chami L.,Flaig A.,Bauer C.,Dourlen P.,Lesaffre M.,Delay C.,Huot L.,Dumont J.,Werkmeister E.,Lafont F.,Mendes T.,Hansmannel F.,Dermaut B.,Deprez B.,Herard A.S.,Dhenain M.,Souedet N.,Pasquier F.,Tulasne D.,Berr C.,Hauw J.J.,Lemoine Y.,Amouyel P.,Mann D.,Deprez R.,Checler F.,Hot D.,Delzescaux T.,Gevaert K.,Lambert J.C.

ADAM30 Downregulates APP-Linked Defects Through Cathepsin D Activation in Alzheimer's Disease.

EBioMedicine

9

278-292

2016

354801

Metcalf P.,Fusek M.

Two crystal structures for cathepsin D: the lysosomal targeting signal and active site.

EMBO J.

12

1293-1302

1993

354802

Baldwin E.T.,Bhat T.N.,Gulnik S.,Hosur M.V.,Sowder R.C. II,Cachau R.E.,Collins J.,Silva A.M.,Erickson J.W.

Crystal structures of native and inhibited forms of human cathepsin D: implications for lysosomal targeting and drug design.

Proc. Natl. Acad. Sci. U.S.A.

90

6796-6800

1993

354803

Papassotiropoulos A.,Bagli M.,Kurz A.,Kornhuber J.,Forstl H.,Maier W.,Pauls J.,Lautenschlager N.,Heun R.

A genetic variation of cathepsin D is a major risk factor for Alzheimer's disease.

Ann. Neurol.

47

399-403

2000

354804

Steinfeld R.,Reinhardt K.,Schreiber K.,Hillebrand M.,Kraetzner R.,Bruck W.,Saftig P.,Gartner J.

Cathepsin D deficiency is associated with a human neurodegenerative disorder.

Am. J. Hum. Genet.

78

988-998

2006

354805

Kousi M.,Lehesjoki A.E.,Mole S.E.

Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses.

Hum. Mutat.

33

42-63

2012